Protective effect of baicalein against endotoxic shock in rats in vivo and in vitro

Biochemical Pharmacology

Volumn 73, Issue 6, 2007, Pages 793-804

  Cheng, Pao Yun ^a   Lee, Yen Mei ^a   Wu, Yuan Sheng ^a   Chang, Tz Wei ^a   Jin, Jong Shiaw ^b   Yen, Mao Hsiung ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Baicalein; Circulatory failure; NF B; Nitric oxide; Reactive oxygen species; Sepsis

Indexed keywords

BAICALEIN; DNA; FLAVONOID; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; SCUTELLARIA BAICALENSIS EXTRACT; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; DNA PROTEIN COMPLEX; DOSE RESPONSE; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; ENDOTOXEMIA; HEMODYNAMICS; HYPOTENSION; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIA; LIVER; LUNG INFILTRATE; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PLANT ROOT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; REPORTER GENE; SCUTELLARIA BAICALENSIS; SEPSIS; SEPTIC SHOCK; SURVIVAL RATE; TACHYCARDIA; UPREGULATION; VASCULAR DISEASE;

ANIMALS; BLOOD PRESSURE; CYTOKINES; ENDOTOXEMIA; FLAVANONES; HEART RATE; MALE; NEUTROPHIL INFILTRATION; NF-KAPPA B; NOREPINEPHRINE; RATS; RATS, INBRED WKY; SHOCK, SEPTIC; SUPEROXIDES; VASOCONSTRICTION;

EID: 33846858005     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.11.025     Document Type: Article

References (52)

1. Bone R.C., Grodzin C.J., and Balk R.A. Sepsis, a new hypothesis for pathogenesis of the disease process. Chest 112 (1997) 235-243
2. Friedman G., Silva E., and Vincent J.L. Has the mortality of septic shock changed with time?. Crit Care Med 26 (1998) 2078-2086
3. Wheeler A.P., and Bernard G.R. Treating patients with severe sepsis. N Engl J Med 340 (1999) 207-214
4. Angus D.C., Linde-Zwirbe W.T., Lidicker J., Clermont G., Carcillo J., and Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29 (2001) 1303-1310
5. Marik P.E., and Zalopa G.P. Therapeutic selection: has its time come?. Crit Care Med 30 (2002) 949-952
6. Brix-Christensen V., Andersen S.K., Andersen R., Mengel A., Dyhr T., Andersen N.T., et al. Acute hyperinsulinemia restrains endotoxin-induced systemic inflammatory response. Anesthesiology 100 (2004) 861-870
7. Marix P.E., and Raghavan M. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med 30 (2004) 748-756
8. Takemura R., and Werb Z. Secretory products of macrophages and their physiological functions. Am J Physiol 1246 (1984) C1-C9
9. Jansen M.J., Hendriks T., Vogels M.T., van der Meer J.W., and Goris R.J. Inflammatory cytokines in an experimental model for the multiple organ dysfunction syndrome. Crit Care Med 24 (1996) 1196-1202
10. Thiemermann C., Wu C.C., Szabo C., Pen'etti M., and Vane J.R. Role of tumor necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock. Br J Pharmacol 110 (1993) 177-182
11. Tracey K.J., and Cerami A. Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 9 (1993) 317-343
12. de Waal M.R., Abrams J., Bennett B., Figdor C.G., and de Vries J.E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174 (1991) 1209-1220
13. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., and O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 147 (1991) 3815-3822
14. Gerard C., Bruyns C., Marchant A., Abramowicz D., Vandenabeele P., Delvanx A., et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 177 (1993) 547-550
15. Yang F., Comtois A.S., Fang L., Hartman N.G., and Blaise G. Nitric oxide-derived nitrate anion contributes to endotoxic shock and multiple organ injury/dysfunction. Crit Care Med 30 (2002) 650-657
16. Szabo C., Salzman A.L., and Ischiropoulos H. Endotoxin triggers the expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in the rat aorta in vivo. FEBS Lett 363 (1995) 235-238
17. Jiang H., Stewart C.A., and Leu R.W. Tumor-derived factor synergizes with IFN-gamma and LPS, IL-2 or TNF-alpha to promote macrophage synthesis of TNF-alpha and TNF receptors for autocrine induction of nitric oxide synthase and enhanced nitric oxide-mediated tumor cytotoxicity. Immunobiology 192 (1995) 321-342
18. Kikkawa I., Saito S., Tominaga K., Hoshino Y., Ooi Y., and Nakano M. Lipopolysaccharide (LPS) stimulates the production of tumor necrosis factor (TNF)-alpha and expression of inducible nitric oxide synthase (iNOS) by osteoclasts (OCL) in murine bone marrow cell culture. Microbiol Immunol 142 (1998) 591-598
19. Sugino K., Dohi K., Yamada K., and Kawasaki T. Changes in the levels of endogenous antioxidants in the liver of mice with experimental endotoxemia and the protective effects of the antioxidants. Surgery 105 (1989) 200-206
20. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., and Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87 (1990) 1620-1624
21. Deitch E.A. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 216 (1992) 117-134
22. Wu C.C., Ruetten H., and Thiemermann C. Comparison of the effects of amino-guanidine and N omega-nitro-l-arginine methyl ester on the multiple organ dysfunction caused by endotoxaemia in the rat. Eur J Pharmacol 300 (1996) 99-104
23. Wu J.A., Attele A.S., Zhang L., and Yuan C.S. Anti-HIV activity of medicinal herbs: usage and potential development. Am J Chin Med 29 (2001) 69-81
24. Bochorakova H., Paulova H., Slanina J., Musil P., and Taborska E. Main flavonoids in the root of Scutellaria baicalensis cultivated in Europe and their comparative antiradical properties. Phytother Res 17 (2003) 640-644
25. Shen Y.C., Chiou W.F., Chou Y.C., and Chen C.F. Mechanisms in mediating the anti-inflammatory effects of baicalin and baicalein in human leukocytes. Eur J Pharmacol 465 (2003) 171-181
26. Kimura Y., Yokoi K., Matsushita N., and Okuda H. Effects of flavonoids isolated from scutellariae radix on the production of tissue-type plasminogen activator and plasminogen activator inhibitor-1 induced by thrombin and thrombin receptor agonist peptide in cultured human umbilical vein endothelial cells. J Pharm Pharmacol 49 (1997) 816-822
27. Zhang D.Y., Wu J., Ye F., Xue L., Jiang S., Yi J., et al. Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis. Cancer Res 63 (2003) 4037-4043
28. Wakabayashi I. Inhibitory effects of baicalein and wogonin on lipo- polysaccharide-induced nitric oxide production in macrophages. Pharmacol Toxicol 84 (1999) 288-291
29. Wu C.C., Chiao C.W., Hsiao G., Chen A., and Yen M.H. Melatonin prevents endotoxin-induced circulatory failure in rats. J Pineal Res 30 (2001) 147-156
30. Liaw W.J., Tzao C., Wu J.Y., Chen S.J., Wang J.H., and Wu C.C. Inhibition by terbutaline of nitric oxide and superoxide anion levels of endotoxin-induced organs injury in the anesthetized rat. Shock 19 (2003) 281-288
31. Hong H.J., Loh S.H., and Yen M.H. Suppression of the development of hypertension by the inhibitor of inducible nitric oxide synthase. Br J Pharmacol 131 (2000) 631-637
32. Chiao C.W., Lee S.S., Wu C.C., and Su M.J. N-acetylsecoboldine as a novel agent prevents acute renal failure during endotoxemia. Eur J Pharmacol 535 (2006) 291-300
33. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1983) 55-63
34. Hernanz R., Alonso M.J., Zibrandtsen H., Alvarez Y., Salaices M., and Simonsen U. Measurements of nitric oxide concentration and hyporeactivity in rat superior mesenteric artery exposed to endotoxin. Cardiovasc Res 62 (2004) 202-211
35. Grossman B.J., Shanley T.P., Odoms K., Dunsmore K.E., Denenberg A.G., and Wong H.R. Temporal and mechanistic effects of heat shock on LPS-mediated degradation of IkappaBalpha in macrophages. Inflammation 26 (2002) 129-137
36. Zhang Y.Y., Don H.Y., Guo Y.Z., Ageta H., Harigaya Y., Onda M., et al. Comparative study of Scutellaria planipes and Scutellaria baicalensis. Biomed Chromatogr 12 (1998) 31-33
37. Cao G., Sofic E., and Prior R.L. Antioxidant and prooxidant behavior of flavonoids: structureactivity relationships. Free Radic Biol Med 22 (1997) 749-760
38. Shieh D.E., Liu L.T., and Lin C.C. Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin. Anticancer Res 20 (2000) 2861-2865
39. Lebeau A., Esclaire F., Rostene W., and Pelaprat D. Baicalein protects cortical neurons from beta-amyloid (25-35) induced toxicity. Neuroreport 12 (2001) 2199-2202
40. Shao Z.H., Vanden Hoek T.L., Qin Y., Becker L.B., Schumacker P.T., Li C.Q., et al. Baicalein attenuates oxidant stress in cardiomyocytes. Am J Physiol Heart Circ Physiol 282 (2002) H999-H1006
41. Titheradge M.A. Nitric oxide in septic shock. Biochim Biophys Acta 1411 (1999) 437-455
42. Thiemermann C. Nitric oxide and septic shock. Gen Pharmacol 29 (1997) 159-166
43. Takano H., Yoshikawa T., Yamaguchi T., Hongo H., Fujii T., Boku Y., et al. Effects of aminoguanidine on systemic inflammatory response syndrome induced by platelet activating factor and by lipopolysaccharide in rats. Eur J Pharmacol 323 (1997) 107-110
44. Paya D., Maupoil V., Schott C., Rochette L., and Stoclet J.C. Temporal relationships between levels of circulating NO derivatives, vascular NO production and hyporeactivity to noradrenaline induced by endotoxin in rats. Cardiovasc Res 30 (1995) 952-959
45. Fleming I., Julou-Schaeffer G., Gray G.A., Parratt J.R., and Stoclet J.C. Evidence that an l-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin. Br J Pharmacol 103 (1991) 1047-1052
46. Schneider F., Bucher B., Schott C., Andre A., Julou-Schaeffer G., and Stoclet J.C. Effect of bacterial lipopolysaccharide on function of rat small femoral arteries. Am J Physiol Heart Circ Physiol 266 (1994) H191-H198
47. Stoclet J.C., Muller B., Andriantsitohaina R., and Kleschyov A. Overproduction of nitric oxide in pathophysiology of blood vessels. Biochemistry 63 (1998) 826-832
48. Suh N., Honda T., Finlay H.J., Barchowsky A., Williams C., Benoit N.E., et al. Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. Cancer Res 58 (1998) 717-723
49. Xie Q.W., Kashiwabara Y., and Nathan C. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem 269 (1994) 4705-4708
50. Shishodia S., and Aggarwal B.B. Nuclear factor-κB activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer. Cancer Treat Res 119 (2004) 139-173
51. Yoshikawa T., Takano H., Takahashi S., Ichikawa H., and Kondo M. Changes in tissue antioxidant enzyme activities and lipid peroxides in endotoxin-induced multiple organ failure. Circ Shock 42 (1994) 53-58
52. Haveman J.W., Muller Kobold A.C., Tervaert J.W., van den Berg A.P., Tulleken J.E., and Kallenberg C.G. The central role of monocytes in the pathogenesis of sepsis: consequences for immunomonitoring and treatment. Neth J Med 55 (1999) 132-141